Who controls biontech se (bntx)?

If you want to know who really controls BioNTech SE ( NASDAQ:BNTX ), then you'll have to look at the makeup of its share registry. The group holding the most number of shares in the company, around 44% to be precise, is private equity firms. In other words, the group stands to gain the most (or lose the most) from their investment into the company.

What is biontech?

BioNTech was founded by scientists and physicians to translate science into survival by combining fundamental research and operational excellence. We at BioNTech believe that the immune system is the fundamental driver for therapeutic success in cancer, and infectious diseases and other serious diseases.

What is biontech – biopharmaceutical new technologies?

Biopharmaceutical New Technologies, or BioNTech, is a global, fully integrated next-generation immunotherapy company pioneering novel therapies for cancer, infectious diseases and other serious diseases. We exploit a wide array of computational discovery and therapeutic drug platforms for the rapid development of novel biopharmaceuticals.